SFX by Ex Libris Inc.

Title:	Genetic susceptibility to neuroblastoma: current knowledge and future directions
Source:	Cell and Tissue Research [0302-766X] Ritenour, Laura yr:2018

Basic

Full text

Full text available via SpringerLINK Contemporary 1997-Present

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Tolbert, Vanessa P. "Neuroblastoma: clinical and biological approach to risk stratification and treatment." Cell & tissue research 372.2 (2018): 195-209.
description	2.	Schulte, M. "Cancer evolution, mutations, and clonal selection in relapse neuroblastoma." Cell and tissue research. 372.2: 263-268.
description	3.	Nguyen, R. "The role of interleukin-2, all-trans retinoic acid, and natural killer cells: surveillance mechanisms in anti-GD2 antibody therapy in neuroblastoma." Cancer Immunology, Immunotherapy 67.4: 615-626.
description	4.	Haybaeck, J. "Genetic and molecular alterations in olfactory neuroblastoma: implications for pathogenesis, prognosis and treatment." Oncotarget. 7.32: 52584-52596.
description	5.	Sharp, Barry E. "Pediatrics: Diagnosis of Neuroblastoma." Seminars in Nuclear Medicine 41.5 (2011): 345-353.
description	6.	Monclair, T. "The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report." Journal of clinical oncology 27.2 (2009): 298-303.
description	7.	Brisse, Herv J. "Guidelines for Imaging and Staging of Neuroblastic Tumors: Consensus Report from the International Neuroblastoma Risk Group Project." Radiology 261.1 (2011): 243-257.
description	8.	Berthold, F. "Review of image defined risk factors in localized neuroblastoma patients: Results of the GPOH NB97 trial." Pediatric blood & cancer (2007): 965-9.
description	9.	Brodeur, G M M. "Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment." Journal of clinical oncology 11.8: 1466-1477.
description	10.	"Clonal selection based intelligent parameter inversion algorithm for prestack seismic data." Information sciences 517: 86-99.
description	11.	Jackson, Jeremy R. "Increased Survival and Decreased Metastasis in a Mouse Neuroblastoma Model of Minimal Residual Disease after Treatment with Anti-GD2 Antibody and Activated Natural Killer Cells." Journal of the American College of Surgeons 223.4 (2016).
description	12.	Zhu, S. "The Clinical Characteristics and Prognosis of Neuroblastoma with Liver Involvement in Children." Pediatric Blood & Cancer 2018.
description	13.	He, C. "Two-Step Targeted Hybrid Nanoconstructs Increase Brain Penetration and Efficacy of the Therapeutic Antibody Trastuzumab against Brain Metastasis of HER2-Positive Breast Cancer." Advanced functional materials. 28.9: 1705668-.
description	14.	Tsubota, S. "Origin and initiation mechanisms of neuroblastoma." Cell & tissue research 372.2 (2018): 211-221.
description	15.	"Type I Interferon-Independent Dendritic Cell Priming and Antitumor T Cell Activation Induced by a Mycoplasma fermentans Lipopeptide." Frontiers in immunology. 9.
description	16.	Cooley, S. "Strategies to activate NK cells to prevent relapse and induce remission following hematopoietic stem cell transplantation." Blood 131.10 (2018): 1053-1062.
description	17.	Tran, Hung C. "TGFβR1 Blockade with Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch14.18) with Natural Killer Cells." Clinical cancer research. 23.3: 804-813.
description	18.	Park, Julie R. "Neuroblastoma: Paradigm for Precision Medicine." The Pediatric clinics of North America 62.1: 225-256.
description	19.	Cook, G. "Miscellaneous indications in bone scintigraphy: metabolic bone diseases and malignant bone tumors." Seminars in Nuclear Medicine 40.1: 52-61.
description	20.	Piepsz, A. "Pediatric applications of renal nuclear medicine." Seminars in nuclear medicine 36.1 (2006): 16-35.